Looks like the biotechs buffs are more intrerested in the smaller spec biotechs than the blue chip in the sector.Just have to wait for Phase II results and this stock should explode. $40+ is very possible
FEX From the Floor question: "When will FEX start using rail to augment & de-risk their haulage solution?" | Fenix Resources
AL8 From the Floor question: "What is the focus of AL8 and how is management going to attract shareholders to the registry?" | Alderan Resources
